Veradermics, Incorporated (MANE) Financial Statements

27 Followers

Veradermics, Incorporated Financial Overview

Veradermics, Incorporated's market cap is currently $3.92B. The company's EPS TTM is $; its P/E ratio is -64.03; Veradermics, Incorporated is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -72.35M	$ -26.78M	$ -17.32M
EBITDA	$ -70.00M	$ -25.90M	$ -16.45M
Net Income	$ -70.00M	$ -26.49M	$ -16.49M
Balance Sheet
Cash & Short-Term Investments	$ 141.86M	$ 53.08M	$ 16.30M
Total Assets	$ 152.62M	$ 59.38M	$ 18.46M
Total Debt	$ 4.00K	$ 0.00	$ 786.00K
Net Debt	$ -21.76M	$ -53.08M	$ -15.51M
Total Liabilities	$ 273.63M	$ 4.72M	$ 3.84M
Stockholders' Equity	$ -121.01M	$ 54.66M	$ 14.62M
Cash Flow
Free Cash Flow	$ -71.63M	$ -23.69M	$ -13.51M
Operating Cash Flow	$ -71.60M	$ -23.69M	$ -13.51M
Investing Cash Flow	$ -118.86M	$ 0.00	$ 0.00
Financing Cash Flow	$ 159.14M	$ 60.48M	$ 13.89M

Currency in USD

Veradermics, Incorporated Earnings and Revenue History

Income Statement >

Veradermics, Incorporated Debt to Assets

Balance Sheet >

Veradermics, Incorporated Cash Flow

Cash Flow >

Veradermics, Incorporated Forecast EPS vs Actual EPS

Earnings >